In the context of autonomic regulation, a double-blind trial published in Biological Psychology subjected participants to acute mental stressors
As of early 2026, compounded GLP-1 medications remain available through licensed pharmacies in many jurisdictions, but the long-term future of GLP-1 compounding depends on factors including manufacturer supply levels, ongoing litigation outcomes, and potential Congressional action
Saxenda (liraglutide) Saxenda is a GLP-1 medication appropriate for adults who: Have obesity (BMI of 30 or above) Have overweight (BMI of 27 or above) along with a weight-related comorbid condition like high blood pressure, type 2 diabetes, or high cholesterol or triglycerides It is also approved for children ages 12 and above who weigh more than 132 pounds and are considered obese
However, in the absence of a stressor, curcumin can exert pro-oxidant effects when directly applied to cells or mitochondria, leading to apoptosis